{"entity":{"type":"insider","cik":"0001780662","url":"/insider/0001780662","json_url":"/insider/0001780662.json","name":"PISKEL KYLE","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":19,"n_filings":16,"first":"2022-03-08","last":"2026-05-20","span_basis":"filed_date"},"name_variants":[{"name":"PISKEL KYLE","source":"filing","n_filings":16,"first_seen":"2022-03-08","last_seen":"2026-05-20"}],"transactions":[{"id":6176280,"accession":"0001780662-26-000013","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001780662-26-000013","line_url":"/filing/0001780662-26-000013#line-1","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780662","owner_name":"PISKEL KYLE","owner_display_name":"PISKEL KYLE","owner_url":"/insider/0001780662","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3115.0,"shares_display":"3,115","price_per_share":13.04,"price_display":"13.04","price_state":"stated","total_value":40619.6,"total_display":"40,619.60","total_whole":"40,620","shares_owned_after":256725.0,"shares_owned_after_display":"256,725","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-18","filed_date":"2026-05-20","scope":"insider"},{"id":6141171,"accession":"0001780662-26-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001780662-26-000006","line_url":"/filing/0001780662-26-000006#line-1","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780662","owner_name":"PISKEL KYLE","owner_display_name":"PISKEL KYLE","owner_url":"/insider/0001780662","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18672.0,"shares_display":"18,672","price_per_share":13.17,"price_display":"13.17","price_state":"stated","total_value":245910.24,"total_display":"245,910.24","total_whole":"245,910","shares_owned_after":259840.0,"shares_owned_after_display":"259,840","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-11","filed_date":"2026-03-13","scope":"insider"},{"id":6004939,"accession":"0001780662-26-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001780662-26-000002","line_url":"/filing/0001780662-26-000002#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780662","owner_name":"PISKEL KYLE","owner_display_name":"PISKEL KYLE","owner_url":"/insider/0001780662","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2145.0,"shares_display":"2,145","price_per_share":18.46,"price_display":"18.46","price_state":"stated","total_value":39596.7,"total_display":"39,596.70","total_whole":"39,597","shares_owned_after":216637.0,"shares_owned_after_display":"216,637","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-04","filed_date":"2026-02-06","scope":"insider"},{"id":6141168,"accession":"0001780662-26-000001","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001780662-26-000001","line_url":"/filing/0001780662-26-000001#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780662","owner_name":"PISKEL KYLE","owner_display_name":"PISKEL KYLE","owner_url":"/insider/0001780662","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4290.0,"shares_display":"4,290","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":77220.0,"total_display":"77,220.00","total_whole":"77,220","shares_owned_after":216637.0,"shares_owned_after_display":"216,637","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":4970535,"accession":"0001780662-25-000003","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001780662-25-000003","line_url":"/filing/0001780662-25-000003#line-4","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780662","owner_name":"PISKEL KYLE","owner_display_name":"PISKEL KYLE","owner_url":"/insider/0001780662","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":162820.0,"shares_display":"162,820","price_per_share":19.5,"price_display":"19.50","price_state":"stated","total_value":3174990.0,"total_display":"3,174,990.00","total_whole":"3,174,990","shares_owned_after":216637.0,"shares_owned_after_display":"216,637","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-28","filed_date":"2025-12-02","scope":"insider"},{"id":4440581,"accession":"0001780662-25-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001780662-25-000002","line_url":"/filing/0001780662-25-000002#line-1","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780662","owner_name":"PISKEL KYLE","owner_display_name":"PISKEL KYLE","owner_url":"/insider/0001780662","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":238.0,"shares_display":"238","price_per_share":14.05,"price_display":"14.05","price_state":"stated","total_value":3343.9,"total_display":"3,343.90","total_whole":"3,344","shares_owned_after":269343.0,"shares_owned_after_display":"269,343","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-17","filed_date":"2025-11-18","scope":"insider"},{"id":9219313,"accession":"0001062993-25-009904","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-25-009904","line_url":"/filing/0001062993-25-009904#line-1","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780662","owner_name":"PISKEL KYLE","owner_display_name":"PISKEL KYLE","owner_url":"/insider/0001780662","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1929.0,"shares_display":"1,929","price_per_share":8.89,"price_display":"8.89","price_state":"stated","total_value":17148.81,"total_display":"17,148.81","total_whole":"17,149","shares_owned_after":269581.0,"shares_owned_after_display":"269,581","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-16","filed_date":"2025-05-20","scope":"insider"},{"id":4167343,"accession":"0001062993-25-009837","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-25-009837","line_url":"/filing/0001062993-25-009837#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780662","owner_name":"PISKEL KYLE","owner_display_name":"PISKEL KYLE","owner_url":"/insider/0001780662","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1929.0,"shares_display":"1,929","price_per_share":8.89,"price_display":"8.89","price_state":"stated","total_value":17148.81,"total_display":"17,148.81","total_whole":"17,149","shares_owned_after":277396.0,"shares_owned_after_display":"277,396","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-16","filed_date":"2025-05-19","scope":"insider"},{"id":4390406,"accession":"0001062993-25-004813","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001062993-25-004813","line_url":"/filing/0001062993-25-004813","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780662","owner_name":"PISKEL KYLE","owner_display_name":"PISKEL KYLE","owner_url":"/insider/0001780662","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10320.0,"shares_display":"10,320","price_per_share":6.9837412790697675,"price_display":"6.98","price_state":"stated","total_value":72072.21,"total_display":"72,072.21","total_whole":"72,072","shares_owned_after":269010.0,"shares_owned_after_display":"269,010","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-05","filed_date":"2025-03-06","scope":"insider","n_lines":3},{"id":2906566,"accession":"0001062993-24-019373","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-24-019373","line_url":"/filing/0001062993-24-019373#line-1","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780662","owner_name":"PISKEL KYLE","owner_display_name":"PISKEL KYLE","owner_url":"/insider/0001780662","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":248.0,"shares_display":"248","price_per_share":4.98,"price_display":"4.98","price_state":"stated","total_value":1235.04,"total_display":"1,235.04","total_whole":"1,235","shares_owned_after":154330.0,"shares_owned_after_display":"154,330","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-18","filed_date":"2024-11-19","scope":"insider"},{"id":2776211,"accession":"0001062993-24-005768","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-24-005768","line_url":"/filing/0001062993-24-005768#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780662","owner_name":"PISKEL KYLE","owner_display_name":"PISKEL KYLE","owner_url":"/insider/0001780662","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7727.0,"shares_display":"7,727","price_per_share":3.43,"price_display":"3.43","price_state":"stated","total_value":26503.61,"total_display":"26,503.61","total_whole":"26,504","shares_owned_after":123318.0,"shares_owned_after_display":"123,318","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-05","filed_date":"2024-03-06","scope":"insider"},{"id":8140104,"accession":"0001062993-23-021224","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-23-021224","line_url":"/filing/0001062993-23-021224#line-1","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780662","owner_name":"PISKEL KYLE","owner_display_name":"PISKEL KYLE","owner_url":"/insider/0001780662","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":259.0,"shares_display":"259","price_per_share":4.13,"price_display":"4.13","price_state":"stated","total_value":1069.67,"total_display":"1,069.67","total_whole":"1,070","shares_owned_after":87305.0,"shares_owned_after_display":"87,305","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-16","filed_date":"2023-11-20","scope":"insider"},{"id":7996515,"accession":"0001062993-23-006330","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001062993-23-006330","line_url":"/filing/0001062993-23-006330","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780662","owner_name":"PISKEL KYLE","owner_display_name":"PISKEL KYLE","owner_url":"/insider/0001780662","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3529.0,"shares_display":"3,529","price_per_share":8.570648909039388,"price_display":"8.57","price_state":"stated","total_value":30245.82,"total_display":"30,245.82","total_whole":"30,246","shares_owned_after":87793.0,"shares_owned_after_display":"87,793","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-06","filed_date":"2023-03-08","scope":"insider","n_lines":2},{"id":9271838,"accession":"0001209191-22-057531","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-057531","line_url":"/filing/0001209191-22-057531#line-1","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780662","owner_name":"PISKEL KYLE","owner_display_name":"PISKEL KYLE","owner_url":"/insider/0001780662","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":307.0,"shares_display":"307","price_per_share":8.87,"price_display":"8.87","price_state":"stated","total_value":2723.09,"total_display":"2,723.09","total_whole":"2,723","shares_owned_after":47358.0,"shares_owned_after_display":"47,358","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-16","filed_date":"2022-11-17","scope":"insider"},{"id":6150211,"accession":"0001209191-22-057432","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-057432","line_url":"/filing/0001209191-22-057432#line-1","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780662","owner_name":"PISKEL KYLE","owner_display_name":"PISKEL KYLE","owner_url":"/insider/0001780662","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":959.0,"shares_display":"959","price_per_share":8.87,"price_display":"8.87","price_state":"stated","total_value":8506.33,"total_display":"8,506.33","total_whole":"8,506","shares_owned_after":46706.0,"shares_owned_after_display":"46,706","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-16","filed_date":"2022-11-17","scope":"insider"},{"id":6454627,"accession":"0001209191-22-017396","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-017396","line_url":"/filing/0001209191-22-017396#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780662","owner_name":"PISKEL KYLE","owner_display_name":"PISKEL KYLE","owner_url":"/insider/0001780662","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":220.0,"shares_display":"220","price_per_share":12.01,"price_display":"12.01","price_state":"stated","total_value":2642.2,"total_display":"2,642.20","total_whole":"2,642","shares_owned_after":47665.0,"shares_owned_after_display":"47,665","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-07","filed_date":"2022-03-08","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":19,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":19,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":19},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001478320","name":"Adaptive Biotechnologies Corp","url":"/issuer/0001478320","role":"Officer (Chief Financial Officer)","n_filings":16,"first_seen":"2022-03-08","last_seen":"2026-05-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001780662","retrieved_at":"2026-08-23T21:36:10+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}